BGI
China - Hong KongBiotechnology
Focus: BGI is a China-based biotechnology company specializing in genetic testing with emerging oncology and immunotherapy programs across rare diseases. The company operates from Hong Kong with a diversified pipeline spanning early-stage cellular and vaccine therapeutics.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Open Jobs
0
About BGI
AI assessmentNot HiringNo open roles listed right now. Follow BGI to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
17 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
undefined
HealthyClinical Trials (1)
NCT05160675Nutrition, Microbiome and Bone Health During Early Life Related to Health
N/AHelp build intelligence for BGI
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.